• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤中骨髓血管生成与增殖指数Ki-67之间的关系。

The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.

作者信息

Alexandrakis M G, Passam F H, Dambaki C, Pappa C A, Stathopoulos E N

机构信息

Department of Haematology, University Hospital of Heraklion, PO Box 1352, 71110, Heraklion, Crete, Greece.

出版信息

J Clin Pathol. 2004 Aug;57(8):856-60. doi: 10.1136/jcp.2003.013110.

DOI:10.1136/jcp.2003.013110
PMID:15280408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1770397/
Abstract

AIM

Angiogenesis correlates with disease progression in various haematological malignancies. This study investigated the association between microvascular density (MVD) and the Ki-67 proliferation index (Ki-67 PI), bone marrow infiltration, and C reactive protein (CRP) in patients with multiple myeloma.

METHODS

Bone marrow MVD was examined in 44 biopsies at diagnosis and 15 in plateau phase by immunostaining the endothelial cells with a monoclonal antibody to CD34. The Ki-67 PI was evaluated by a double immunostaining technique using the monoclonal antibodies MIB-1 and CD38.

RESULTS

MVD, Ki-67 PI, bone marrow infiltration, and CRP were significantly higher in pretreatment patients than in controls and decreased in patients achieving plateau phase. MVD significantly correlated with Ki-67 PI and infiltration, and Ki-67 correlated with infiltration.

CONCLUSION

In multiple myeloma, apart from being a marker of proliferative activity, Ki-67 is also associated with bone marrow angiogenesis and tumour burden.

摘要

目的

血管生成与多种血液系统恶性肿瘤的疾病进展相关。本研究调查了多发性骨髓瘤患者微血管密度(MVD)与Ki-67增殖指数(Ki-67 PI)、骨髓浸润及C反应蛋白(CRP)之间的关联。

方法

通过用抗CD34单克隆抗体对内皮细胞进行免疫染色,在44例诊断时的骨髓活检标本及15例平台期标本中检测骨髓MVD。采用MIB-1和CD38单克隆抗体的双重免疫染色技术评估Ki-67 PI。

结果

预处理患者的MVD、Ki-67 PI、骨髓浸润及CRP显著高于对照组,且在达到平台期的患者中降低。MVD与Ki-67 PI及浸润显著相关,且Ki-67与浸润相关。

结论

在多发性骨髓瘤中,Ki-67除作为增殖活性标志物外,还与骨髓血管生成及肿瘤负荷相关。

相似文献

1
The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.多发性骨髓瘤中骨髓血管生成与增殖指数Ki-67之间的关系。
J Clin Pathol. 2004 Aug;57(8):856-60. doi: 10.1136/jcp.2003.013110.
2
Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.利用CD19、CD45、CD56、CD38和CD138对多发性骨髓瘤患者骨髓浆细胞进行流式细胞术评估及其与骨髓浸润率的相关性
Saudi Med J. 2004 Nov;25(11):1587-92.
3
Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.多发性骨髓瘤中的骨髓血管生成及其与临床病理因素的相关性。
Ann Hematol. 2010 Aug;89(8):789-94. doi: 10.1007/s00277-010-0919-z. Epub 2010 Feb 23.
4
Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.骨髓血管生成在多发性骨髓瘤中的预后价值:利用光学显微镜以及计算机图像分析仪评估多发性骨髓瘤中的微血管密度和总血管面积及其与各种临床、组织学和实验室参数的相关性。
Am J Hematol. 2006 Sep;81(9):649-56. doi: 10.1002/ajh.20639.
5
Positive correlation between bone marrow mast cell density and ISS prognostic index in patients with multiple myeloma.多发性骨髓瘤患者骨髓肥大细胞密度与 ISS 预后指数呈正相关。
Leuk Res. 2013 Dec;37(12):1628-31. doi: 10.1016/j.leukres.2013.09.012. Epub 2013 Sep 21.
6
Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.流式细胞术检测多发性骨髓瘤患者骨髓、外周血及外周血干细胞采集中的非整倍体CD38(++)浆细胞和CD19(+) B淋巴细胞。
Leuk Res. 2004 May;28(5):469-77. doi: 10.1016/j.leukres.2003.09.015.
7
Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.核因子κB受体活化因子配体在骨髓浆细胞上的表达与多发性骨髓瘤患者的溶骨性骨病相关。
Clin Cancer Res. 2003 Apr;9(4):1436-40.
8
Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activity.
Int J Immunopathol Pharmacol. 2004 Jan-Apr;17(1):49-56. doi: 10.1177/039463200401700107.
9
Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.多发性骨髓瘤患者中血管内皮生长因子的表达及微血管密度:临床及预后意义
Med Oncol. 2008;25(4):451-7. doi: 10.1007/s12032-008-9066-y. Epub 2008 May 1.
10
DNA topoisomerase IIalpha in multiple myeloma: a marker of cell proliferation and not drug resistance.多发性骨髓瘤中的DNA拓扑异构酶IIα:一种细胞增殖标志物而非耐药标志物。
Mod Pathol. 2001 Sep;14(9):886-91. doi: 10.1038/modpathol.3880407.

引用本文的文献

1
A rare case of CD38-negative abdominal multiple extramedullary plasmacytoma and literature review.1例罕见的CD38阴性腹部多发性髓外浆细胞瘤及文献复习
Leuk Res Rep. 2024 Dec 21;23:100493. doi: 10.1016/j.lrr.2024.100493. eCollection 2025.
2
Differentiating low- and high-proliferative soft tissue sarcomas using conventional imaging features and radiomics on MRI.利用传统成像特征和MRI上的放射组学区分低增殖性和高增殖性软组织肉瘤。
BMC Cancer. 2024 Dec 30;24(1):1589. doi: 10.1186/s12885-024-13339-7.
3
Immunophenotypic expression profile of multiple myeloma cases at a tertiary hospital in Nairobi Kenya.肯尼亚内罗毕一家三级医院多发性骨髓瘤病例的免疫表型表达谱
Front Med (Lausanne). 2023 May 12;10:1177775. doi: 10.3389/fmed.2023.1177775. eCollection 2023.
4
Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors.组织蛋白酶D抑制垂体神经内分泌肿瘤中的血管生成。
Acta Histochem Cytochem. 2022 Dec 28;55(6):203-211. doi: 10.1267/ahc.22-00098. Epub 2022 Dec 20.
5
Proliferation and Angiogenesis Using Immunohistochemistry in Prognosticating Multiple Myeloma.利用免疫组织化学检测增殖与血管生成以预测多发性骨髓瘤的预后
Indian J Hematol Blood Transfus. 2016 Dec;32(4):418-423. doi: 10.1007/s12288-016-0642-6. Epub 2016 Jan 19.
6
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.内皮糖蛋白的免疫组化表达为多发性骨髓瘤中骨髓新生血管形成提供了可靠的评估。
J Cancer Res Clin Oncol. 2015 Aug;141(8):1503-9. doi: 10.1007/s00432-015-1952-z. Epub 2015 Mar 13.
7
Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases.套细胞淋巴瘤的微血管密度。对177例患者进行回顾性研究,分析其预后作用以及与Ki-67和套细胞淋巴瘤国际预后指数的相关性。
Virchows Arch. 2014 Nov;465(5):587-97. doi: 10.1007/s00428-014-1632-4. Epub 2014 Jul 22.
8
Angiogenesis and proliferation index in patients with acute leukemia: a prospective study.急性白血病患者的血管生成与增殖指数:一项前瞻性研究。
Bone Marrow Res. 2014;2014:634874. doi: 10.1155/2014/634874. Epub 2014 Mar 31.
9
The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.白细胞介素-6可溶性受体与多发性骨髓瘤中血管生成细胞因子及增殖标志物之间的关系
Tumour Biol. 2013 Apr;34(2):859-64. doi: 10.1007/s13277-012-0618-6. Epub 2012 Dec 16.
10
Biological aspects of angiogenesis in multiple myeloma.多发性骨髓瘤中血管生成的生物学方面。
Int J Hematol. 2011 Dec;94(6):505-18. doi: 10.1007/s12185-011-0963-z. Epub 2011 Nov 17.

本文引用的文献

1
Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.多发性骨髓瘤患者循环血清可溶性白细胞介素-6受体与血管生成细胞因子碱性成纤维细胞生长因子和血管内皮生长因子之间的关系
Ann Hematol. 2003 Jan;82(1):19-23. doi: 10.1007/s00277-002-0558-0. Epub 2002 Dec 18.
2
The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma.
Clin Lab Haematol. 2003 Feb;25(1):41-6. doi: 10.1046/j.1365-2257.2003.00492.x.
3
Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial.
Int J Hematol. 2002 Dec;76(5):465-70. doi: 10.1007/BF02982813.
4
Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.多西他赛(泰索帝)对体外内皮细胞功能及体内血管生成的抑制作用:与微管组织中心重新定位受损相关
Mol Cancer Ther. 2002 Nov;1(13):1191-200.
5
Bone marrow angiogenesis in multiple myeloma: effect of therapy.多发性骨髓瘤中的骨髓血管生成:治疗效果
Br J Haematol. 2002 Dec;119(3):665-71. doi: 10.1046/j.1365-2141.2002.03871.x.
6
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.400例意义未明的单克隆丙种球蛋白病、多发性骨髓瘤和原发性淀粉样变性患者的骨髓血管生成
Clin Cancer Res. 2002 Jul;8(7):2210-6.
7
Angiogenesis in hematologic malignancies.血液系统恶性肿瘤中的血管生成
Ann Hematol. 2001 Dec;80(12):695-705. doi: 10.1007/s00277-001-0398-3. Epub 2001 Nov 14.
8
Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.多发性骨髓瘤患者骨髓血管生成与浆细胞浸润及血清β2-微球蛋白水平的关系
Ann Hematol. 2001 Oct;80(10):598-601. doi: 10.1007/s002770100361.
9
Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy.化疗后获得缓解的骨髓瘤患者骨髓血管生成减少。
Eur J Haematol. 2001 Apr;66(4):238-44. doi: 10.1034/j.1600-0609.2001.066004238.x.
10
Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.p53、p21/Waf-1、Rb、p16和Ki67蛋白在多发性骨髓瘤中的免疫组化表达
Anticancer Res. 2000 Nov-Dec;20(6B):4619-25.